Fierce Pharma

AUGUST 8, 2024

Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. government. | The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8 million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox.

Government 347

Government 347

MedCity News

AUGUST 8, 2024

More than 700 hospitals across the rural U.S. are at risk of closing due to their financial woes — and for more than half of these hospitals, the risk of closure is immediate, according to a new report. The report argued this is due largely to inadequate reimbursement from health plans. The post Why More Than 30% of Rural Hospitals Are at Risk of Closure appeared first on MedCity News.

Healthcare 135

Healthcare Healthcare 135

Fierce Pharma

AUGUST 8, 2024

It was 2020 and Maryland biotech Novavax was thinking big. It had a plan to become a COVID vaccine powerhouse, with enough manufacturing capacity to supply the U.S. | As Novavax presented its quarterly earnings, finance chief Jim Kelly said the company was “actively exploring” the sale of its manufacturing facility in the Czech Republic. Novavax purchased the site in May of 2020 for $167 million with the intent of it producing more than 1 billion doses annually there.

Manufacturing 319

Manufacturing Sales Government 319

MedCity News

AUGUST 8, 2024

This potential for self-management can reduce the burden on the healthcare system, resulting in fewer doctor visits, lower hospitalization risks, and fewer diagnostic tests as patients can take corrective action earlier or identify issues sooner. The post Wearable Tech is Empowering Patients To Be Proactive in Their Health appeared first on MedCity News.

Patients 133

Patients Doctors Healthcare Healthcare 133

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

AUGUST 8, 2024

While a glut of drugmakers have raised their 2024 financial guidance after the second quarter, those upgraded sales expectations pale in comparison to Eli Lilly’s new forecast for the year. | Lilly, which reported a 36% sales increase year-over-year to $11.3 billion in the second quarter, is raising its guidance for the full year by a staggering $3 billion.

Sales 312

Sales 312

PharmaTimes

AUGUST 8, 2024

The study predicted the development of conditions including Alzheimer’s and heart disease

123

123

pharmaphorum

AUGUST 8, 2024

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million

Pharma 119

Pharma 119

Fierce Pharma

AUGUST 8, 2024

While Apellis Pharmaceuticals has spent much of the year working around setbacks that derailed the ongoing launch of its geographic atrophy (GA) drug Syfovre, a major phase 3 triumph could open up | Empaveli showed strong efficacy in two rare kidney diseases. The result “exceeded our already high expectations," an Apellis exec said, and it led analysts at Evercore ISI to assign the drug a majority future market share against Novartis’ rival.

Pharmaceutical 293

Pharmaceutical Marketing 293

pharmaphorum

AUGUST 8, 2024

Roche is said to be considering a sale of cancer data specialist Flatiron Health, just a few years after it bought the company for $1.

Sales 118

Sales 118

Fierce Pharma

AUGUST 8, 2024

After taking a market share lead in the crowded Humira biosimilar space and with other key launches in the works, Novartis spinout Sandoz is raising its full-year sales guidance. | The company touts leading biosimilar market share for its version of AbbVie's Humira.

Sales 290

Sales Leads Marketing 290

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

AUGUST 8, 2024

Through a new partnership with FarmboxRx, Blue Cross Blue Shield of Tennessee members will receive healthy food deliveries after they complete preventive health screenings, like a diabetic eye exam. The post Blue Cross Blue Shield of Tennessee Taps FarmboxRx for Food as Medicine Initiative appeared first on MedCity News.

Food 117

Food Medicine 117

Fierce Pharma

AUGUST 8, 2024

Three large pharma companies are locked in a high-stakes antibody-drug conjugate race. Merck and Daiichi Sankyo teamed up on a DLL3 T-cell engager. | Three large pharma companies are locked in a high-stakes antibody-drug conjugate race. Merck and Daiichi Sankyo teamed up on a DLL3 T-cell engager. Eisai inked a molecular glue degrader deal with BeyondSpring that could be worth up to $1.5 billion.

Pharma 130

Pharma 130

pharmaphorum

AUGUST 8, 2024

Novartis gets FDA accelerated approval for Fabhalta in IgA nephropathy as it charts a course to blockbuster sales for the drug

FDA 111

FDA Sales 111

Pharmaceutical Technology

AUGUST 8, 2024

Novartis has secured US Food and Drug Administration (FDA) accelerated approval for Fabhalta (iptacopan) to treat igAN.

Food and Drug Administration 105

Food and Drug Administration FDA Food 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Commerce

AUGUST 8, 2024

In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, discusses the state of affairs surrounding the Drug Supply Chain Security Act, along with opportunities for improvement.

Pharma 105

Pharma 105

Pharmaceutical Technology

AUGUST 8, 2024

Conduit plans to advance two assets, AZD1656 and AZD5658, into Phase II testing for autoimmune disorders.

105

105

pharmaphorum

AUGUST 8, 2024

NICE backs Vertex's gene-editing therapy Casgevy as a treatment for beta thalassaemia, a few months after turning it down for sickle cell disease

104

104

Pharmaceutical Technology

AUGUST 8, 2024

Coming in response to a rise in teenage overdoses across the US, the Purdue auto-injector device is designed to be used by anyone.

105

105

Advertisement

Pharmaceutical Commerce

AUGUST 8, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 104

Distribution Biopharma Marketing Pharma 104

MedCity News

AUGUST 8, 2024

Addressing America’s maternal health crisis will be complicated and nuanced. Here are a few possible solutions. The post Rural America’s Maternity Crisis: How Locum Tenens Can Help Fill Gaps in Rural Hospitals’ Labor and Delivery Services appeared first on MedCity News.

Healthcare 101

Healthcare Healthcare 101

PharmaTimes

AUGUST 8, 2024

Lung cancer accounts for an estimated two million global diagnoses and 1.

99

99

Pharmaceutical Commerce

AUGUST 8, 2024

Will the looming changes address the concerns of the patient assistance community?

Patients 98

Patients 98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

AUGUST 8, 2024

UK drive for research, trial subjects hits key milestone Phil.

97

97

Pharmaceutical Technology

AUGUST 8, 2024

The contract will see bulk product for Jynneos replenished and additional services for dose storage.

96

96

PharmaTech

AUGUST 8, 2024

The reopening of comments addresses the addition of a warning to consumers that acetaminophen may cause skin irritation characterized by reddening, blisters, and rashes.

FDA 69

FDA 69

Pharmaceutical Technology

AUGUST 8, 2024

The gene editing therapy will now be accessible to NHS England patients with beta-thalassemia, potentially replacing lifelong transfusions.

Patients 64

Patients 64

Advertisement

Distribution

PharmaTech

AUGUST 8, 2024

A holistic approach to automation can provide benefits at all stages of development and manufacturing.

Manufacturing 64

Manufacturing 64

PharmaVoice

AUGUST 8, 2024

The top drugs at each of the world’s most valuable pharma companies tell the story of just how much the industry has changed over the course of a few years.

Marketing 64

Marketing Pharma 64

Pharmacy Times

AUGUST 8, 2024

The injection adds an additional option to address emergency known or suspected opioid overdoses.

FDA 55

FDA 55

Pharmaceutical Technology

AUGUST 8, 2024

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals' CREXONT extended-release capsules for PD.

Food and Drug Administration 52

Food and Drug Administration FDA Food Pharmaceutical 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales